EVERY GREAT RIVER BEGINS AS A SMALL STREAM

 
 
torrent small.jpg
 
 

TORRENT VENTURES INVESTS IN EARLY STAGE, CALIFORNIA-based COMPANIES PURSUING THE MOST DYNAMIC medical technology AND DIGITAL HEALTH OPPORTUNITIES. WITH OFFICES IN LOS ANGELES AND SAN DIEGO, THE FIRM HAS DEEP RELATIONSHIPS WITH ACADEMIC AND CORPORATE CENTERS OF INNOVATION FOR GENOMICS, diagnostics, medical devices, DRUG DELIVERY, AND DIGITAL HEALTH TECHNOLOGIES.

 
 
 

TEAM 

 

 

 
LUKE HAYES.jpg
 

LUKE HAYES

Co-Founder and Managing Director

Luke Hayes is Co-Founder and Managing Director at Torrent Ventures. Luke has been active in venture investing in Los Angeles for more than a decade and loves the adventure of working with early stage companies.

Luke's work in life sciences goes back nearly 20 years when he was responsible for developing licensing opportunities for a micelle-based drug delivery technology. Since then he has had business development responsibilities for clients such as Lilly, Abbott, and Sigma-Aldrich in addition to serving as an advisor for Roswell Biotechnologies, a genetic sequencing company. Luke is a firm believer that an increase in global healthcare demand over the coming decades will spur massive amounts of innovation.

Luke earned a B.S. in Chemical Engineering from Brigham Young University and an M.B.A. from the UCLA Anderson School of Management. Luke lived in Brazil for two years and, when not immersed in venture investing, enjoys wrestling with his four boys, volunteering in his local church congregation, and tagging along with his wife, Reagan, on her work trips to Vietnam.

 
Greg Mckee.jpg
 

GREG MCKEE

Co-Founder and Managing Director

Greg McKee is Co-Founder and Managing Director at Torrent Ventures. Greg brings more than 20 years of management and investment experience in life sciences and is a fixture within the San Diego startup community.

Greg most recently served as CEO of CONNECT, a business accelerator focused on creating and scaling innovative companies in the life sciences and technology sectors. Greg was previously Chairman and CEO of Nventa Biopharmaceuticals and Akela Pharma, both publicly traded biotech companies. Greg also served in senior management positions for Genzyme in Boston and Singapore.

Greg started his career working in finance and policy in Tokyo where, over his 7 years there, he became fluent in both Japanese and high end sushi. Greg earned a B.A. in Economics from the University of Washington, an M.B.A. from the Wharton School, and an M.A. in International Studies from the Joseph H. Lauder Institute at the Univeristy of Pennsylvania. He is an active YPO member and can be found swimming in the La Jolla Shores almost daily or contemplating his next alpine climbing expedition.

 
 
 

LOS ANGELES

10250 CONSTELLATION BLVD

SUITE 100

LOS ANGELES, CA 90067

SAN DIEGO

12670 HIGH BLUFF DRIVE

SAN DIEGO, CA 92130

 
 

INFO@TORRENTVENTURES.COM